AERIE PHARMACEUTIC (Germany) Today

Equity ratings for AERIE PHARMACEUTIC DL are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of July 2021 and ending today, the 28th of September 2021. Click here to learn more.
AERIE PHARMACEUTIC DL cannot be verified against its exchange. It appears AERIE PHARMACEUTIC is not available for investing at the moment. Please verify the symbol is currently traded on Frankfurt Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

AERIE PHARMACEUTIC Stock Profile

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, retinal diseases, and other eye diseases. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina. AERIE PHARMACEUTIC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 353 people.. The public information regarding AERIE PHARMACEUTIC DL's current market price is not available at this time.
AERIE PHARMACEUTIC is not yet fully synchronised with the market data
AERIE PHARMACEUTIC has some characteristics of a very speculative penny stock
The company reported the revenue of 35.03 M. Net Loss for the year was (239.82 M) with loss before overhead, payroll, taxes, and interest of (3 M).
AERIE PHARMACEUTIC DL has accumulated about 148.87 M in cash with (160.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.24.
Over 92.0% of the company shares are owned by institutions such as pension funds
Legal NameAERIE PHARMACEUTIC DL
Chairman of the Board, CEOVicente Anido  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of AERIE PHARMACEUTIC's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
AERIE PHARMACEUTIC DL (0P0) is traded on Frankfurt Stock Exchange in Germany and employs 353 people. The company currently falls under 'Small-Cap' category with current market capitalization of 928.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AERIE PHARMACEUTIC's market, we take the total number of its shares issued and multiply it by AERIE PHARMACEUTIC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. AERIE PHARMACEUTIC classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 45.92 M outstanding shares. AERIE PHARMACEUTIC DL has accumulated about 148.87 M in cash with (160.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.24.
Check AERIE PHARMACEUTIC Probability Of Bankruptcy

AERIE Stock Against Markets

Picking the right benchmark for AERIE PHARMACEUTIC stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AERIE PHARMACEUTIC stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AERIE PHARMACEUTIC is critical whether you are bullish or bearish towards AERIE PHARMACEUTIC DL at a given time.
AERIE PHARMACEUTIC DL cannot be verified against its exchange. It appears AERIE PHARMACEUTIC is not available for investing at the moment. Please verify the symbol is currently traded on Frankfurt Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AERIE PHARMACEUTIC stock to make a market-neutral strategy. Peer analysis of AERIE PHARMACEUTIC could also be used in its relative valuation, which is a method of valuing AERIE PHARMACEUTIC by comparing valuation metrics with similar companies.

AERIE PHARMACEUTIC Corporate Directors

AERIE PHARMACEUTIC corporate directors refer to members of an AERIE PHARMACEUTIC board of directors. The board of directors generally takes responsibility for the AERIE PHARMACEUTIC's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AERIE PHARMACEUTIC's board members must vote for the resolution. The AERIE PHARMACEUTIC board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
David Gryska - Independent DirectorProfile
Julie McHugh - Independent DirectorProfile
Benjamin McGraw - Independent DirectorProfile
Anand Mehra - DirectorProfile
Check out Trending Equities. Note that the AERIE PHARMACEUTIC information on this page should be used as a complementary analysis to other AERIE PHARMACEUTIC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Tools for AERIE Stock

When running AERIE PHARMACEUTIC price analysis, check to measure AERIE PHARMACEUTIC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AERIE PHARMACEUTIC is operating at the current time. Most of AERIE PHARMACEUTIC's value examination focuses on studying past and present price action to predict the probability of AERIE PHARMACEUTIC's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AERIE PHARMACEUTIC's price. Additionally, you may evaluate how the addition of AERIE PHARMACEUTIC to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go